Delivery Order SPE2DB22D1106-SPE2DB24FDVB3
Award Date 1/13/24
Potential Completion Date 1/16/24
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $1,890.02 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine products. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
- The Defense Logistics Agency awarded a delivery order valued at $11,147.44 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML vaccine product. This firm fixed-price, competitively awarded contract was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.30 firm fixed-price delivery order is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $5,307.34 award is for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product, with a performance period through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen...
- The Defense Logistics Agency awarded a $397 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pediatric hepatitis B vaccine from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements by August 1, 2023. As a leading provider of medical supplies and pharmaceuticals to the Department of Defense, Amerisourcebergen supports the DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $2,962.72 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This is a $1,346.35 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical distribution company. The order is for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a completion date of February 20, 2024 and was awarded on February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,985.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical distribution company. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,967.56 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support military treatment programs and facilities. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,369.33 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML Vial, a hepatitis B vaccine product. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran...